Patients with cancer and COVID-19 had high rates of hospitalization and/or respiratory illness, particularly among those taking immunotherapy or those older than 65 years.
Upon starting methotrexate treatment, LDH and albumin levels may be signals for AKIs in patients with hematologic malignancies.
11% of interpretations were different for TP53 gene; difference can impact management.
Genome-wide association studies have revealed over 180 SNPs associated with increased breast cancer risk.
Quality of life significantly lower than reference group; symptom scales worse, including insomnia.
Consistent underrepresentation seen in clinical trials evaluating medications across major cancer types.
Replacing sedentary time with 30 minutes of light or moderate physical activity cuts risk.
This fact sheet discusses associations between anticancer therapies and outcomes of COVID-19 among patients with cancer.
The Food and Drug Administration (FDA) has approved Nyvepria™ (pegfilgrastim-apgf; Pfizer), a biosimilar to Neulasta (pegfilgrastim; Amgen). Nyvepria, a leukocyte growth factor, is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anticancer drugs associated with a clinically significant incidence of febrile neutropenia. The approval…
Urologists will be facing a tremendous backlog due to the COVID-19 quarantine.
